Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02108054 · ClinicalTrials.gov registry record · NA

Behavioral and Functional Task Development, Implementation, and Testing

A NA study of Alcohol Use Disorder and Alcohol Drinking, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

Recruiting
Registry status
NA
Development phase
400
Enrollment target
1
Study location

NCT02108054: Recruiting NA study of Alcohol Use Disorder and Alcohol Drinking, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

NCT02108054 is a NA study of Alcohol Use Disorder and Alcohol Drinking that is actively recruiting participants, run by National Institute on Alcohol Abuse and Alcoholism (NIAAA). The registered enrollment target is 400 participants, above the 326-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (23% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02108054, a NA study of Alcohol Use Disorder and Alcohol Drinking, is actively recruiting participants, sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA).

RECRUITING
Registry status
NA
Development phase
400 participants
Enrollment target
1
Study location

Study Summary

Background: \- Scientists know that alcohol use disorders affect brain structure. They want to know more about the effects of alcohol use disorders on a person s behavior. They want to develop tasks that can be done inside a scanner that can help them better understand these effects in later studies. Objective: \- To develop tasks that investigate a person s behavior that can be used in later studies. Eligibility: * Inpatient participants of another study. They must be physically healthy right-handed adults 18-60 years old. * Healthy right-handed volunteers 18-65 years old. Design: * Participants will be screened with medical history and physical exam. They will have an EKG to record heart activity. They will give blood and urine samples and have a psychiatric interview. * Participants will have between one and three visits. * Participants will be asked about their alcohol drinking to see if they have an alcohol use disorder. * Participants will complete one of three simple computerized tasks either inside the magnetic resonance imagining (MRI) scanner or outside of it. * The MRI scanner takes pictures of the brain. The scanner is a metal cylinder. Participants lie on a table that can slide in and out of the cylinder. They will be in the scanner for about 60 minutes. They may have to lie still for up to 20 minutes. The scanner makes loud knocking noises, but they will get earplugs.

Primary Outcome

Tasks that are suitable for fMRI studies and other clinical research measurements

Interventions

  • DEVICE 7T MRI

Study Locations (1)

Maryland

  • National Institutes of Health Clinical Center - Bethesda

Trial Details

FieldValue
Enrollment Target 400 participants
Start Date 2014-05-28
Est. Completion 2026-12-31
Phase NA

What NCT02108054 shows while recruiting

NCT02108054 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, above the 326-participant average among 184 other Alcohol Use Disorder trials with a reported enrollment target (23% higher).

The record links to 5 conditions, with Alcohol Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which 7T MRI is the first listed.

NCT02108054 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT02108054 about?

NCT02108054 is a clinical study titled "Behavioral and Functional Task Development, Implementation, and Testing". Background: \- Scientists know that alcohol use disorders affect brain structure. They want to know more about the effects of alcohol use disorders on a person s behavior. They want to develop tasks that can be done inside a scanner that can help them better understand these effects in later studie...

What is the current status of trial NCT02108054?

This trial is currently recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2014-05-28. Estimated completion is 2026-12-31.

What conditions does trial NCT02108054 study?

This clinical trial studies the following conditions: Alcohol Use Disorder, Alcohol Drinking, Alcoholism, Alcohol Dependence, Addiction.

What interventions are being tested in trial NCT02108054?

The interventions under investigation include: 7T MRI (DEVICE).

Who is sponsoring clinical trial NCT02108054?

This trial is sponsored by National Institute on Alcohol Abuse and Alcoholism (NIAAA), which has 93 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02108054 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Alcohol Use Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02108054's enrollment target sits among peer trials

400 19th of 184 higher than 163 of 184 other Alcohol Use Disorder trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Alcohol Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01665326 · 400 participants

    Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease

  • NCT02216500 · 400 participants · NA

    Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy

  • NCT02250352 · 400 participants

    Core Biopsies for Establishing a Breast Tumor Tissue Repository

  • NCT02285582 · 400 participants

    International Rare Histiocytic Disorders Registry (IRHDR)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02108054, the US trial registry maintained by the National Library of Medicine. NCT02108054 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.